ResearcherThe Royal Free HospitalNo recent work listed
Goran Hamid Mohammad
Matched on ORCID iD 0000-0003-4822-1497; OpenAlex author ID A5051952180. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper
Papers 3
- Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer. Co-author DOI 10.3390/cancers11091372↗
- Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients. Co-author DOI 10.1158/1078-0432.ccr-17-1185↗
- Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome. Co-author DOI 10.1371/journal.pone.0151635↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen P. Pereira · 3 shared papers, 2016–2019 · strength 0.27
- Paper Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Panc… DOI 10.3390/cancers11091372↗
- Paper Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patie… DOI 10.1158/1078-0432.ccr-17-1185↗
- Paper Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome. DOI 10.1371/journal.pone.0151635↗
- Steven W.M. Olde Damink · 2 shared papers, 2016–2019 · strength 0.18
- Paper Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Panc… DOI 10.3390/cancers11091372↗
- Paper Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome. DOI 10.1371/journal.pone.0151635↗
- Pilar Acedo Núñez · 1 shared paper, 2019 · strength 0.11
- Yuan Chen · 1 shared paper, 2017 · strength 0.08
- Emma C. Morris · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.